Global Computed Tomography (CT) Devices Market is expected to grow at a CAGR of 6.36% during the forecast period from 2022 to 2027 to reach USD 8.87 billion by 2027| DelveInsight

As per DelveInsight Analysis in the Computed Tomography (CT) Devices market, the rise in the incidence of chronic diseases such as cardiovascular, oncological, and others, along with the rapid advancements in technology are likely to propel the global Computed Tomography (CT) devices market.

According to the latest report published by DelveInsight "Computed Tomography (CT) Devices, Market Insight, Competitive Landscape & Market Forecast - 2027," the global Computed Tomography (CT) Devices market is projected to witness considerable growth due to an upsurge in the cases of severe chronic diseases such as cardiovascular, oncological and others, rapid technological advancements in product design, increased awareness of early diagnosis, coupled with the rise in geriatric population, is expected to bolster the growth of the Computed Tomography (CT) Devices market during the forecast period from 2022-2027.

Interested in knowing how the Computed Tomography (CT) Devices Market will be growing by 2027? Click to get a snapshot of the Computed Tomography (CT) Devices Market Analysis: https://www.delveinsight.com/report-store/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Computed Tomography (Ct) Devices Market Insights
According to the US Food and Drug Association (FDA), Computed Tomography (CT) is a device that helps physicians to diagnose a range of conditions by producing images of internal organs and structures of the body. A CT scanner is an x-ray machine that combines many x-ray images with the aid of a computer to generate cross-sectional views and, if needed, three-dimensional images of the internal organs and structures of the body.

The rising incidence of chronic diseases of various types such as cardiovascular, oncological, and other diseases is one of the key factors driving the growth of the Computed Tomography (CT) devices market. For instance, as per the reports from International Agency for Research on Cancer, WHO (2021), around 1.2 million young adults (aged 20-39) were diagnosed with cancer globally in the year 2020, causing 360,000 deaths.

Hence, early detection is essential for the cure because survival is dependent on the treatment pathway for the disease. By early detection through CT scans, the diagnosis of the disease becomes efficient and precise, giving way for treatment processes to start more quickly. Therefore, due to the increasing incidence of chronic diseases like cancer, the demand for CT scanners may increase during the forecast period driving the growth of the Computed Tomography Devices market, during the forecast period from 2022-2027.

Another key factor behind the growth of the Computed Tomography (CT) devices market is the rising geriatric population around the world. According to the data provided by the World Health Organization (2020), about one billion people across the world were over the age of 60 in the year 2019. The source further stated that by 2050, the geriatric population is further expected to double in number estimated to about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. Age is one of the main risk factors associated with the development of many chronic conditions, thereby, the increasing geriatric population is expected to escalate the cases of chronic diseases, leading to an increase in the demand for Computed Tomography (CT) Devices, thus driving the Computed Tomography (CT) Devices market growth during the forecast period from 2022-2027.

Request for Sample Report: https://www.delveinsight.com/report-store/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Geography-Wise Computed Tomography (CT) Devices Market Analysis
Geographically, the global Computed Tomography (CT) Devices market is studied for North America, Europe, Asia-Pacific, and for Rest of the World. In terms of revenue share, North America currently leads the global market and is projected to hold its market position during the study period, owing to various factors such as the rising cancer cases, increase in the utilization of CT, technical improvements, strong financial incentives, and increased product launches in the regions, which eventually is expected to aid the growth of North America Computed Tomography Devices Market.
The cases of cancer are continuously increasing in the North American region. As per reports by the American Cancer Society (2022) 1.9 million cancer cases were diagnosed and 609,360 cancer deaths occurred in the United States in 2021. The source further stated that more than 1.9 million new cancer cases were expected to be diagnosed in the United States in 2022.

In addition to the increase in the cases of chronic diseases like cancer, another factor responsible for the growth of the Computed Tomography Devices market is the increased emphasis on product development activities and the high interest of device manufacturers which further aid in the growth of regional markets for Computed Tomography Devices. For example, in October 2021, Siemens Healthineers got the Food and Drug Administration (FDA) 510 (k) clearance for its product called Naeotom Alpha, the world's first photon-counting computer tomography.
These kinds of product launches and approvals in the local markets by key players in the Computed Tomography (CT) devices may drive the product demand in the market. Therefore, the interplay of factors such as the presence of a large patient population along with the encouragement of new product launches in the region is expected to boost the North America Computed Tomography Devices market during the forecast period.

To know more about why North America is leading the market growth in the Computed Tomography (CT) Devices market, get a snapshot of the report Computed Tomography (CT) Devices market: https://www.delveinsight.com/report-store/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developmental Activities in the Computed Tomography (CT) Devices Market:
• On May 19, 2021, Royal Philips announced the launch of its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed Tomography (CT) 7500. This latest intelligent system delivers high-quality spectral images for every patient on every scan 100% of the time to help improve disease characterization and reduce rescans and follow-ups, all at the same dose levels as conventional scans.
• On February 18, 2021, Hitachi announced the conclusion of the absorption-type company split agreement relating to diagnostic imaging-related business (CT, MRI, X-RAY) to Fujifilm. This acquisition expanded FUJIFILM'S business in Medical Systems.
• On December 16, 2020, FUJIFILM announced a CT partnership with UroPartners and chose to standardize the Persona CT Computed Tomography (CT) system to accelerate its oncology treatment planning capabilities. Designed and built in the US, the Persona CT is an innovative CT system from Fujifilm in partnership with Analogic. The system offers advanced oncology simulation and general radiography imaging capabilities with a focus on the patient experience.
• Thus, owing to such developments in the market, there will be rapid growth observed in the Computed Tomography devices market during the forecast period.

Covid-19 Impact Analysis
The unprecedented outbreak of the COVID-19 pandemic has been uplifting the growth of the Computed Tomography (CT) devices market. CT Scans are one of the diagnostic tools for COVID-19 along with laboratory tests. For instance, background chest CT was used in the diagnosis of coronavirus disease and was an essential complement to reverse-transcription polymerase chain reaction (RT-PCR) tests. This resulted in the increased demand for Computed Tomography Devices during the pandemic. Moreover, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post-pandemic has led to the resumption of healthcare services for other modalities also, keeping the demand for these products on course in the Computed Tomography (CT) Devices market.

To discuss more about the short/long-term impact of COVID-19 get a snapshot of the report Computed Tomography (CT) devices market: https://www.delveinsight.com/report-store/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Computed Tomography Segment Analysis
Further global Computed Tomography (CT) Devices market is categorized By Type (Stationary CT Scanners, Portable CT Scanners), Modality (O-arm, C-arm), Technology (Low end, Mid end, High end), Application (Oncology, Cardiology, Neurology, Others), End-User (Hospitals, Diagnostic Imaging Centers, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
The technology category of the Computed Tomography Devices market consisting of the High-end scanners are estimated to hold a larger share in the Computed Tomography Devices market during the forecast period (2022-2027) which can be attributed to the specific features associated with these devices like strong installation base of systems, present globally. Key market players having a strong portfolio are currently involved in the development of 256 slice scanner systems. These systems help in scanning an organ, including the brain, heart, entire joints, lungs, and liver. Another added characteristic associated with High-end scanners is that they have superior imaging qualities possessing higher spatial resolution.

Therefore, considering the advantages and technological superiorities associated with High-end systems, this product category is expected to generate a significant revenue share, eventually contributing to the overall growth of the global Computed Tomography Devices market during the forecast period.

Computed Tomography Market Segmentation
By Type
• Stationary CT Scanners
• Portable CT Scanners
By Modality
• C-Arm
• O-Arm
By Technology
• Low end
• Mid end
• High end
By Application
• Oncology
• Cardiology
• Neurology
• Others
By End-User
• Hospitals
• Diagnostic Imaging Centers
• Others
By Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World

Computed Tomography Market Scope
• Study Period: 2019-2027
• Key Companies: General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, and others.
• Segmentation: By Type, By Modality, By Technology, By Application, By End-User, and By Geography
• Geography Covered: North America, Europe, Asia-Pacific, Rest of the World
• Analysis: The Computed Tomography (CT) Devices market is estimated to grow at a CAGR of 6.36% during the forecast period from 2022 to 2027 to reach USD 8.87 billion by 2027.
 
Know more about the scope of the report: https://www.delveinsight.com/report-store/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Computed Tomography (CT) Devices Market Report Introduction
2. Computed Tomography (CT) Devices Market Executive summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial benchmarking
3. Regulatory Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. Computed Tomography (CT) Devices Market Key factors analysis
4.1. Computed Tomography (CT) Devices Market Drivers
4.1.1. Rising incidence of severe types of chronic disorders that are oncological, cardiovascular, and neurological
4.1.2. Increasing old age population
4.1.3. Growing technological developments by key players and product approvals
4.2. Computed Tomography (CT) Devices Market Restraints and Challenges
4.2.1. High cost of equipment
4.2.2. Doses of harmful ionizing radiations during scanning
4.3. Computed Tomography (CT) Devices Market Opportunities
4.3.1. The rise in market opportunities in developing nations
4.3.2. Opportunities owing to technological advancements
5. Computed Tomography (CT) Devices Market Porter's Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 Impact Analysis on Computed Tomography (CT) Devices Market
7. Computed Tomography (CT) Devices Market layout
7.1. By Type
7.2. By Modality
7.3. By Technology
7.4. By Application
7.5. By End-User
7.6. By Geography
8. Computed Tomography (CT) Devices Global Company Share Analysis - Key 3-5 Companies
9. Computed Tomography (CT) Devices Market Company and Product Profiles
9.1. General Electric Company
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. FUJIFILM Holdings Corporation
9.3. Siemens Healthcare GmbH
9.4. Koninklijke Philips N.V.
9.5. Canon Medical Systems Corporation
9.6. Xoran Technologies LLC
9.7. Shimadzu Corp.
9.8. Thermo Fisher Scientific
9.9. NeuroLogica Corp.
9.10. MARS Bioimaging Ltd.
More companies will be provided in the final coverage.
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Request for Sample Report: https://www.delveinsight.com/sample-request/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:

Pediatric Obesity Market: https://www.delveinsight.com/report-store/pediatric-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Acanthamoeba Keratitis Market: https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Nr2e3 Mutation Associated Retinal Degeneration Market: https://www.delveinsight.com/report-store/nr2e3-mutation-associated-retinal-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Italy Healthcare Outlook Report: https://www.delveinsight.com/report-store/italy-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.